| Cure Sickle Cell Initiative Clinical Trial Stage Projects | University of California, San Francisco | Transplantation of CRISPR-CAS9 Corrected Hematopoietic Stem Cells (CRISPR_SCD001) in Patients with Severe Sickle Cell Disease |
$8,389,407 |
| Conference – The 2019 Alpha Stem Cell Clinic Annual Symposium | University of California, San Francisco | 2019 Alpha Stem Cell Clinic Symposium – Mending Stem Cells: The Past, Present & Future Regenerative Medicine |
$60,000 |
| Alpha Stem Cell Clinics Network Expansion | University of California, San Francisco | University of California, San Francisco (UCSF) Alpha Stem Cell Clinic (ASCC) |
$7,994,347 |
| Alpha Stem Cell Clinics Network Expansion | University of California, San Francisco | University of California, San Francisco (UCSF) CIRM Alpha Stem Cell Clinic |
$5,087,847 |
| Therapeutic Translational Research Projects | University of California, San Francisco | Curing Sickle cell Disease with CRISPR-Cas9 genome editing |
$60,635 |
| Late Stage Preclinical Projects | University of California, San Francisco | Curing Sickle cell Disease with CRISPR-Cas9 genome editing |
$2,242,805 |
